Drug Safety Issues are Only Detected after Approval
In One-Third of Drugs, Safety Issues Identified after Approval A new study published in the Journal of the American Medical Association (JAMA) highlights the need for ongoing safety monitoring after drugs are approved and sold. Researchers found that, in about one-third of drugs approved by the U.S. Food and Drug Administration … [Read more...] about Drug Safety Issues are Only Detected after Approval
Avandia Bisphosphonate Weaknesses Problems
Avandia, Bisphosphonate Problems. Recent safety issues involving the diabetes drug Avandia and a class of bone drugs called bisphosphonates have some questioning the way drugs are approved for sale in the US. According to a recent New York Times’ news analysis, problems that have cropped up with Avandia, bisphosphonates and other … [Read more...] about Avandia Bisphosphonate Weaknesses Problems
